T2 Biosystems | 8-K: T2 Biosystems Announces Third Quarter 2024 Financial Results
T2 Biosystems | 10-Q: Q3 2024 Earnings Report
T2 Biosystems | 8-K: T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results
T2 Biosystems | 10-Q: Q2 2024 Earnings Report
T2 Biosystems | 8-K: T2 Biosystems Announces Second Quarter 2024 Financial Results
T2 Biosystems | 8-K: T2 Biosystems Announces First Quarter 2024 Financial Results
T2 Biosystems | 10-Q: Q1 2024 Earnings Report
T2 Biosystems | 10-K: FY2023 Annual Report
T2 Biosystems | 8-K: T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results
T2 Biosystems | 10-Q: Q3 2023 Earnings Report
T2 Biosystems | 8-K: T2 Biosystems Announces Preliminary Third Quarter 2023 Financial Results and FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2Bacteria Panel
T2 Biosystems | 8-K: T2 Biosystems Announces Second Quarter 2023 Financial Results
T2 Biosystems | 10-Q: Q2 2023 Earnings Report
T2 Biosystems | 8-K: T2 Biosystems Announces First Quarter 2023 Financial Results
T2 Biosystems | 10-Q: Q1 2023 Earnings Report
T2 Biosystems | 10-K: FY2022 Annual Report
T2 Biosystems | 8-K: T2 Biosystems Announces Fourth Quarter and Full Year 2022 Financial Results
T2 Biosystems | 8-K: T2 Biosystems announced preliminary fourth quarter and full year 2022 financial results, entered into the Term Loan Agreement and a 10-year lease agreement
T2 Biosystems | 10-Q: Q3 2022 Earnings Report
T2 Biosystems | 8-K: T2 Biosystems Announces Third Quarter 2022 Financial Results and Holds a Conference Call to Discuss Those Results
No Data
No Data